相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer
Agnieszka Zaczek et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Proteomic responses to oxidative damage in meat from ducks exposed to heat stress
Jun He et al.
FOOD CHEMISTRY (2019)
Bystander effects of ionizing radiation: conditioned media from X-ray irradiated MCF-7 cells increases the angiogenic ability of endothelial cells
Nasrollah Jabbari et al.
CELL COMMUNICATION AND SIGNALING (2019)
Angiogenic potential of YKL-40 in the dynamics of tumor niche
Ayda Pouyafar et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Vascular endothelial growth factor signaling in development and disease
Sinem Karaman et al.
DEVELOPMENT (2018)
Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation
Georg Lorenz et al.
KIDNEY INTERNATIONAL (2018)
Chitinase 3 like 1 (CHI3L1) promotes vasculogenic mimicry formation in cervical cancer
Nipaporn Ngernyuang et al.
PATHOLOGY (2018)
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer
Christopher Darr et al.
UROLOGIA INTERNATIONALIS (2018)
Preoperative serum levels of YKL 40 and CA125 as a prognostic indicators in patients with endometrial cancer
Beata Kotowicz et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma
Zhi Zhang et al.
ONCOLOGY LETTERS (2016)
Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer
Pinar Kemik et al.
GYNECOLOGIC ONCOLOGY (2016)
Effects of a Small Interfering RNA Targeting YKL-40 Gene on the Proliferation and Invasion of Endometrial Cancer HEC-1A Cells
Li-li Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway
Zengyang Yu et al.
SCIENTIFIC REPORTS (2016)
YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer
Malvin Jefri et al.
BMC CANCER (2015)
Serum YKL-40 in Risk Assessment for Colorectal Cancer: A Prospective Study of 4,496 Subjects at Risk of Colorectal Cancer
Julia S. Johansen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Endometrial cancer: A review and current management strategies: Part I
William M. Burke et al.
GYNECOLOGIC ONCOLOGY (2014)
Improving oncologic outcomes for women with endometrial cancer: Realigning our sights
Sean C. Dowdy
GYNECOLOGIC ONCOLOGY (2014)
YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line
Yasuto Akiyama et al.
ONCOLOGY REPORTS (2014)
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer
Stephan Tschirdewahn et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer
Anita Monika Chudecka-Glaz et al.
JOURNAL OF OVARIAN RESEARCH (2014)
The diagnostic and prognostic value of serum YKL-40 in endometrial cancer
Jiang-tao Fan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS
Takashi Yoshioka et al.
GYNECOLOGIC ONCOLOGY (2013)
YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
Rong Shao
FRONTIERS IN PHYSIOLOGY (2013)
Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers
R. Shao et al.
BRITISH JOURNAL OF CANCER (2011)
Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma
Ralph A. Francescone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers
Michael Faibish et al.
MOLECULAR CANCER THERAPEUTICS (2011)
YKL-40 Protein Levels and Clinical Outcome of Human Endometrial Cancer
C. Peng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
YKL-40-an emerging biomarker in cardiovascular disease and diabetes
Camilla N. Rathcke et al.
CARDIOVASCULAR DIABETOLOGY (2009)
Plasma YKL-40: a potential new cancer biomarker?
Julia S. Johansen et al.
FUTURE ONCOLOGY (2009)
Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells
J. Dai et al.
ONCOGENE (2009)
YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
R. Shao et al.
ONCOGENE (2009)
Is YKL-40 a new therapeutic target in cancer?
Julia S. Johansen et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Preoperative serum YK-L-40 is a marker for detection and prognosis of endometrial cancer
Catherine S. M. Diefenbach et al.
GYNECOLOGIC ONCOLOGY (2007)
Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA 125)
B. Gronlund et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2006)
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer
H Dehn et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
